CPT-11 and concomitant hyperfractionated accelerated radiotherapy induce efficient local control in rectal cancer patients: results from a phase II

por Voelter, V, Zouhair, A, Vuilleumier, H, Matter, M, Bouzourene, H, Leyvraz, S, Bauer, J, Coucke, P, Stupp, R
Publicado 2006

Preoperative elevation of serum C – reactive protein is predictive for prognosis in myeloma bone disease after surgery

por Zahlten-Hinguranage, A, Goldschmidt, H, Cremer, F W, Egerer, G, Moehler, T, Witte, D, Bernd, L, Sabo, D, Zeifang, F
Publicado 2006

Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide

por Cebon, J
Publicado 2006

Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer

por Harder, J, Riecken, B, Kummer, O, Lohrmann, C, Otto, F, Usadel, H, Geissler, M, Opitz, O, Henß, H
Publicado 2006

Identification of gene polymorphisms of human DNA topoisomerase I in the National Cancer Institute panel of human tumour cell lines

por Moisan, F, Longy, M, Robert, J, Le Morvan, V
Publicado 2006

Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer

por Carpenter, B, McKay, M, Dundas, S R, Lawrie, L C, Telfer, C, Murray, G I
Publicado 2006

Evaluation of models to predict BRCA germline mutations

por Kang, H H, Williams, R, Leary, J, Ringland, C, Kirk, J, Ward, R
Publicado 2006

Antineoplastic effects of rosiglitazone and PPARγ transactivation in neuroblastoma cells

por Cellai, I, Benvenuti, S, Luciani, P, Galli, A, Ceni, E, Simi, L, Baglioni, S, Muratori, M, Ottanelli, B, Serio, M, Thiele, C J, Peri, A
Publicado 2006

Phase II and pharmacological study of oral paclitaxel (Paxoral) plus ciclosporin in anthracycline-pretreated metastatic breast cancer

por Helgason, H H, Kruijtzer, C M F, Huitema, A D R, Marcus, S G, ten Bokkel Huinink, W W, Schot, M E, Schornagel, J H, Beijnen, J H, Schellens, J H M
Publicado 2006

The multikinase inhibitor midostaurin (PKC412A) lacks activity in metastatic melanoma: a phase IIA clinical and biologic study

por Millward, M J, House, C, Bowtell, D, Webster, L, Olver, I N, Gore, M, Copeman, M, Lynch, K, Yap, A, Wang, Y, Cohen, P S, Zalcberg, J
Publicado 2006

Socioeconomic and geographic determinants of survival of patients with digestive cancer in France

por Dejardin, O, Remontet, L, Bouvier, A M, Danzon, A, Trétarre, B, Delafosse, P, Molinié, F, Maarouf, N, Velten, M, Sauleau, E A, Bourdon-Raverdy, N, Grosclaude, P, Boutreux, S, De Pouvourville, G, Launoy, G
Publicado 2006

Randomised study of adjuvant chemotherapy for completely resected p-stage I–IIIA non-small cell lung cancer

por Nakagawa, K, Tada, H, Akashi, A, Yasumitsu, T, Iuchi, K, Taki, T, Kodama, K
Publicado 2006

Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO)

por Brandes, A A, Tosoni, A, Cavallo, G, Bertorelle, R, Gioia, V, Franceschi, E, Biscuola, M, Blatt, V, Crinò, L, Ermani, M
Publicado 2006

(18)FDG uptake during induction chemoradiation for oesophageal cancer fails to predict histomorphological tumour response

por Gillham, C M, Lucey, J A, Keogan, M, Duffy, G J, Malik, V, Raouf, A A, O'Byrne, K, Hollywood, D, Muldoon, C, Reynolds, J V
Publicado 2006

A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas

por Duran, I, Kortmansky, J, Singh, D, Hirte, H, Kocha, W, Goss, G, Le, L, Oza, A, Nicklee, T, Ho, J, Birle, D, Pond, G R, Arboine, D, Dancey, J, Aviel-Ronen, S, Tsao, M-S, Hedley, D, Siu, L L
Publicado 2006

Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer

por Kailash, U, Soundararajan, C C, Lakshmy, R, Arora, R, Vivekanandhan, S, Das, B C
Publicado 2006

Long-term outcome among men with conservatively treated localised prostate cancer

por Cuzick, J, Fisher, G, Kattan, M W, Berney, D, Oliver, T, Foster, C S, Møller, H, Reuter, V, Fearn, P, Eastham, J, Scardino, P
Publicado 2006

The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens

por Steele, J C, Torr, E E, Noakes, K L, Kalk, E, Moss, P A, Reynolds, G M, Hubscher, S G, van Lohuizen, M, Adams, D H, Young, L S
Publicado 2006

The role of socio-economic status in the decision making on diagnosis and treatment of oesophageal cancer in The Netherlands

por van Vliet, E P M, Eijkemans, M J C, Steyerberg, E W, Kuipers, E J, Tilanus, H W, van der Gaast, A, Siersema, P D
Publicado 2006

A specific cadherin phenotype may characterise the disseminating yet non-metastatic behaviour of pseudomyxoma peritonei

por Bibi, R, Pranesh, N, Saunders, M P, Wilson, M S, O'Dwyer, S T, Stern, P L, Renehan, A G
Publicado 2006